“The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s93. Accessed October 5, 2025. https://skin.dermsquared.com/skin/article/view/1063.